Wilms' tumor--model of a curable pediatric malignant solid tumor

Area of Science:

• Pediatric Oncology
• Solid Tumor Treatment
• Cancer Therapeutics

Background:

• Wilms' tumor serves as a model for pediatric solid tumor treatment.
• Initial treatment involved nephrectomy, radiation, and chemotherapy, achieving high survival rates.
• Prognostic factors have been identified, necessitating treatment re-evaluation.

Purpose of the Study:

• To re-examine Wilms' tumor treatment strategies.
• To identify key prognostic factors influencing treatment decisions.
• To guide future therapeutic developments for Wilms' tumor.

Main Methods:

• Review of established multi-modality therapy protocols.
• Analysis of prognostic factors including histology, tumor weight, lymph node status, and age.
• Evaluation of current treatment outcomes for risk stratification.

Main Results:

• Multi-modality therapy (nephrectomy, radiation, chemotherapy) initially showed high disease-free survival.
• Prognostic factors significantly impact treatment effectiveness and patient outcomes.
• Risk-adapted strategies are emerging for Wilms' tumor management.

Conclusions:

• Wilms' tumor treatment is shifting towards personalized medicine.
• Less intensive therapy may be suitable for specific patient groups.
• New treatment paradigms are needed for patients with poor prognoses.